Literature DB >> 3092050

The relation of apolipoproteins A-I and B in children to parental myocardial infarction.

D S Freedman, S R Srinivasan, C L Shear, F A Franklin, L S Webber, G S Berenson.   

Abstract

Clinical studies suggest that serum levels of apolipoproteins A-I and B may be more strongly related to coronary artery disease than are their respective lipoprotein-cholesterol fractions. Therefore, we assessed the association between levels of apolipoprotein B, apolipoprotein A-I, lipids, and lipoprotein cholesterols in children and the reported histories of myocardial infarction in their parents in a survey of 2416 black and white school-age children. As compared with children whose fathers did not report a myocardial infarction, those whose fathers reported having had an infarction (n = 139) had a lower mean level of apolipoprotein A-I (137 vs. 141 mg per deciliter; P = 0.04) and a lower ratio of low-density lipoprotein cholesterol to apolipoprotein B (1.08 vs. 1.11; P = 0.007), along with a higher ratio of apolipoprotein B to apolipoprotein A-I (0.64 vs. 0.61; P = 0.04). These associations existed independently of the children's race, sex, age, and history of obesity, smoking, alcohol intake, and use of oral contraceptives. Children whose mothers reported having had a myocardial infarction (n = 56) had no decrease in the ratio of low-density lipoprotein cholesterol to apolipoprotein B, but they tended to have an elevated ratio of apolipoprotein B to apolipoprotein A-I. In contrast, serum lipoprotein-cholesterol fractions in children were not related to myocardial infarctions in either parent. These results provide further evidence that apolipoproteins are more strongly related to the risk of cardiovascular disease than are lipoprotein-cholesterol fractions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092050     DOI: 10.1056/NEJM198609183151202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

Review 2.  Genetic influences on susceptibility to atherosclerosis in the young.

Authors:  P O Kwiterovich
Journal:  Bull N Y Acad Med       Date:  1989-12

Review 3.  Treatment of dyslipidemia in children and adolescents.

Authors:  Kathryn Wood Holmes; Peter Oscar Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

4.  Cholesteryl ester storage disease: risk factors for atherosclerosis in a 15-year-old boy.

Authors:  R Longhi; C Vergani; R Valsasina; E Riva; C Galluzzo; C Agostoni; M Giovannini
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 6.  Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus.

Authors:  Laura E Schanberg; Christy Sandborg
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

7.  Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India.

Authors:  Ramachandran Meenakshisundaram; Chinnasamy Rajendiran; Ponniah Thirumalaikolundusubramanian
Journal:  Tob Induc Dis       Date:  2010-10-05       Impact factor: 2.600

Review 8.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

9.  Genetic determination of plasma apolipoprotein AI in a population-based sample.

Authors:  P P Moll; V V Michels; W H Weidman; B A Kottke
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

10.  High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

Authors:  M Barbir; D Wile; I Trayner; V R Aber; G R Thompson
Journal:  Br Heart J       Date:  1988-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.